Clinical Trials · NCT00690235
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Texas Southwestern Medical Center
- Enrollment
- 33
- Start date
- Nov 2007
- Locations
- 1 site, United States
- Primary endpoint
- Weight Loss With Pramlintide in Persons With Schizophrenia Who Have Gained Weight Taking Olanzapine or Clozapine